Mifepristone, a blocker of glucocorticoid receptors, promotes photoreceptor death

Investigative Ophthalmology and Visual Science

Volumn 54, Issue 1, 2013, Pages 313-322

  Cubilla, Marisa A ^a   Bermúdez, Vicente ^a   Marquioni Ramella, Melisa D ^a   Bachor, Tomás P ^a   Suburo, Angela M ^a  

^a UNIVERSIDAD AUSTRAL   (Argentina)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE 3; CEFTAZIDIME; DEXAMETHASONE; MIFEPRISTONE; PROTEIN BAX; PROTEIN BCL XL; RHODOPSIN; GLUCOCORTICOID RECEPTOR; HORMONE ANTAGONIST;

ADRENALECTOMY; ANIMAL EXPERIMENT; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL DEATH; CONTROLLED STUDY; DNA DAMAGE; DNA REPAIR; DNA STRAND BREAKAGE; HISTOLOGY; HOMEOSTASIS; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MALE; MOUSE; NICK END LABELING; NONHUMAN; PHOTORECEPTOR; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; SINGLE DRUG DOSE; WESTERN BLOTTING; ANIMAL; BAGG ALBINO MOUSE; COMPARATIVE STUDY; DISEASE MODEL; DRUG ANTAGONISM; DRUG EFFECT; ELECTRORETINOGRAPHY; METABOLISM; PATHOLOGY; PHOTORECEPTOR CELL; RETINA DEGENERATION;

ANIMALS; APOPTOSIS; BLOTTING, WESTERN; DISEASE MODELS, ANIMAL; ELECTRORETINOGRAPHY; HORMONE ANTAGONISTS; IMMUNOHISTOCHEMISTRY; IN SITU NICK-END LABELING; MALE; MICE; MICE, INBRED BALB C; MIFEPRISTONE; PHOTORECEPTOR CELLS, VERTEBRATE; RECEPTORS, GLUCOCORTICOID; RETINAL DEGENERATION;

MLCS; MLOWN;

EID: 84874534397     PISSN: 01460404     EISSN: 15525783     Source Type: Journal    
DOI: 10.1167/iovs.12-10014     Document Type: Article

References (63)

1. Edelman JL. Differentiating intraocular glucocorticoids. Ophthalmologica. 2010;224:25-30.
2. Yu-Wai-Man P, Griffiths PG. Steroids for traumatic optic neuropathy. Cochrane Database Syst Rev. 2011;1:CD006032.
3. Campochiaro PA, Hafiz G, Shah SM, et al. Sustained ocular delivery of fluocinolone acetonide by an intravitreal insert. Ophthalmology. 2010;117:1393-1399. e3.
4. Aref AA, Scott IU. Management of macular edema secondary to central retinal vein occlusion: an evidence-based. Adv Ther. 2011;28:40-50.
5. Boscia F, Furino C, Dammacco R, Ferreri P, Sborgia L, Sborgia C. Intravitreal triamcinolone acetonide in refractory pseudophakic cystoid macular edema: functional and anatomic results. Eur J Ophthalmol. 2005;15:89-95.
6. Jonas JB, Kreissig I, Degenring R. Intravitreal triamcinolone acetonide for treatment of intraocular proliferative, exudative, and neovascular diseases. Prog Retin Eye Res. 2005;24:587-611.
7. Sallam A, Taylor SR, Lightman S. Review and update of intraocular therapy in noninfectious uveitis. Curr Opin Ophthalmol. 2011;22:517-522.
8. Horgan N, Shields CL, Mashayekhi A, Shields JA. Classification and treatment of radiation maculopathy. Curr Opin Ophthalmol. 2010;21:233-238.
9. Augustin A. Triple therapy for age-related macular degeneration. Retina. 2009;29:S8-11.
10. Fu J, Lam TT, Tso MO. Dexamethasone ameliorates retinal photic injury in albino rats. Exp Eye Res. 1992;54:583-594.
11. Wenzel A, Grimm C, Seeliger MW, et al. Prevention of photoreceptor apoptosis by activation of the glucocorticoid receptor. Invest Ophthalmol Vis Sci. 2001;42:1653-1659.
12. Gu D, Beltran WA, Pearce-Kelling S, Li Z, Acland GM, Aguirre GD. Steroids do not prevent photoreceptor degeneration in the light-exposed T4R rhodopsin mutant dog retina irrespective of AP-1 inhibition. Invest Ophthalmol Vis Sci. 2009;50: 3482-3494.
13. Brown J Jr, Hacker H, Schuschereba ST, Zwick H, Lund DJ, Stuck BE. Steroidal and nonsteroidal antiinflammatory medications can improve photoreceptor survival after laser retinal photocoagulation. Ophthalmology. 2007;114:1876-1883.
14. Takahashi K, Lam TT, Fu J, Tso MO. The effect of high-dose methylprednisolone on laser-induced retinal injury in primates: an electron microscopic study. Graefes Arch Clin Exp Ophthalmol. 1997;235:723-732.
15. Glybina IV, Kennedy A, Ashton P, Abrams GW, Iezzi R. Photoreceptor neuroprotection in RCS rats via low-dose intravitreal sustained-delivery of fluocinolone acetonide. Invest Ophthalmol Vis Sci. 2009;50:4847-4857.
16. Cubilla MA, Castañeda MM, Bachor TP, Suburo AM. Glucocorticoid-dependent mechanisms in photoreceptor survival. Adv Exp Med Biol. 2012;723:101-106.
17. Viegas LR, Hoijman E, Beato M, Pecci A. Mechanisms involved in tissue-specific apoptosis regulated by glucocorticoids. J Steroid Biochem Mol Biol. 2008;109:273-278.
18. Kfir-Erenfeld S, Sionov RV, Spokoini R, Cohen O, Yefenof E. Protein kinase networks regulating glucocorticoid-induced apoptosis of hematopoietic cancer cells: fundamental aspects and practical considerations. Leuk Lymphoma. 2010;51: 1968-2005.
19. Yang N, Zhang H, Si-Ma H, et al. Dexamethasone decreases hepatocellular carcinoma cell sensitivity to cisplatin-induced apoptosis. Hepatogastroenterology. 2011;58:1730-1735.
20. Scoltock AB, Heimlich G, Cidlowski JA. Glucocorticoids inhibit the apoptotic actions of UV-C but not Fas ligand in hepatoma cells: direct evidence for a critical role of Bcl-xL. Cell Death Differ. 2007;14:840-850.
21. Nieuwenhuis B, Luth A, Kleuser B. Dexamethasone protects human fibroblasts from apoptosis via an S1P3-receptor subtype dependent activation of PKB/Akt and Bcl XL. Pharmacol Res. 2010;61:449-459.
22. Almeida OF, Conde GL, Crochemore C, et al. Subtle shifts in the ratio between pro-and antiapoptotic molecules after activation of corticosteroid receptors decide neuronal fate. FASEB J. 2000;14:779-790.
23. Foley LP. Common surgical procedures in rodents. In: Reuter JD, Suckow MA, eds. Laboratory Animal Medicine and Management. Ithaca, NY: International Veterinary Information Service; 2005:B2515.0605.
24. Torbidoni V, Iribarne M, Ogawa L, Prasanna G, Suburo AM. Endothelin-1 and endothelin receptors in light-induced retinal degeneration. Exp Eye Res. 2005;81:265-275.
25. Tanito M, Kaidzu S, Anderson RE. Delayed loss of cone and remaining rod photoreceptor cells due to impairment of choroidal circulation after acute light exposure in rats. Invest Ophthalmol Vis Sci. 2007;48:1864-1872.
26. van Attikum H, Gasser SM. Crosstalk between histone modifications during the DNA damage response. Trends Cell Biol. 2009;19:207-217.
27. Chrousos GP, Kino T. Intracellular glucocorticoid signaling: a formerly simple system turns stochastic. Sci STKE. 2005;pe48.
28. Organisciak DT, Vaughan DK. Retinal light damage: mechanisms and protection. Prog Retin Eye Res. 2010;29:113-134.
29. Zimmerman TJ, Dawson WW, Fitzgerald CR. ERG in human eyes following oral adrenocorticoids. Invest Ophthalmol. 1973;12:777-779.
30. Abraham I, Palhalmi J, Szilagyi N, Juhasz G. Glucocorticoids alter recovery processes in the rat retina. Neuroreport. 1998; 9:1465-1468.
31. Oakley RH, Cidlowski JA. Cellular processing of the glucocorticoid receptor gene and protein: new mechanisms for generating tissue specific actions of glucocorticoids. J Biol Chem. 2011;286:3177-3184.
32. Zanchi NE, Filho MA, Felitti V, Nicastro H, Lorenzeti FM, Lancha AH Jr. Glucocorticoids: extensive physiological actions modulated through multiple mechanisms of gene regulation. J Cell Physiol. 2010;224:311-315.
33. Schoch GA, D'Arcy B, Stihle M, et al. Molecular switch in the glucocorticoid receptor: active and passive antagonist conformations. J Mol Biol. 2010;395:568-577.
34. Lewis-Tuffin LJ, Jewell CM, Bienstock RJ, Collins JB, Cidlowski JA. Human glucocorticoid receptor beta binds RU-486 and is transcriptionally active. Mol Cell Biol. 2007;27:2266-2282.
35. McEwen BS. Glucocorticoids, depression, and mood disorders: structural remodeling in the brain. Metabolism. 2005;54:20-23.
36. Dutt M, Tabuena P, Ventura E, Rostami A, Shindler KS. Timing of corticosteroid therapy is critical to prevent retinal ganglion cell loss in experimental optic neuritis. Invest Ophthalmol Vis Sci. 2010;51:1439-1445.
37. Smit-McBride Z, Modjtahedi SP, Cessna CT, Telander DG, Hjelmeland LM, Morse LS. In vivo gene expression profiling of retina postintravitreal injections of dexamethasone and triamcinolone at clinically relevant time points for patient care. Invest Ophthalmol Vis Sci. 2011;52:8965-8978.
38. Noguchi KK, Walls KC, Wozniak DF, Olney JW, Roth KA, Farber NB. Acute neonatal glucocorticoid exposure produces selective and rapid cerebellar neural progenitor cell apoptotic death. Cell Death Differ. 2008;15:1582-1592.
39. Amaral JD, Sola S, Steer CJ, Rodrigues CM. Role of nuclear steroid receptors in apoptosis. Curr Med Chem. 2009;16: 3886-3902.
40. Levin LA, Schlamp CL, Spieldoch RL, Geszvain KM, Nickells RW. Identification of the bcl-2 family of genes in the rat retina. Invest Ophthalmol Vis Sci. 1997;38:2545-2553.
41. He L, Perkins GA, Poblenz AT, et al. Bcl-xL overexpression blocks bax-mediated mitochondrial contact site formation and apoptosis in rod photoreceptors of lead-exposed mice. Proc Natl Acad Sci U S A. 2003;100:1022-1027.
42. Redon CE, Nakamura AJ, Martin OA, Parekh PR, Weyemi US, Bonner WM. Recent developments in the use of gamma-H2AX as a quantitative DNA double-strand break biomarker. Aging (Albany NY). 2011;3:168-174.
43. Aziz MH, Shen H, Maki CG. Glucocorticoid receptor activation inhibits p53-induced apoptosis of MCF10Amyc cells via induction of protein kinase C{epsilon}. J Biol Chem. 2012; 287:29825-29836.
44. Heikinheimo O, Raivio T, Honkanen H, Ranta S, Janne OA. Termination of pregnancy with mifepristone and prostaglandin suppresses transiently circulating glucocorticoid bioactivity. J Clin Endocrinol Metab. 2003;88:323-326.
45. Kino T, Manoli I, Kelkar S, Wang Y, Su YA, Chrousos GP. Glucocorticoid receptor (GR) beta has intrinsic, GRalphaindependent transcriptional activity. Biochem Biophys Res Commun. 2009;381:671-675.
46. Ligr M, Li Y, Logan SK, et al. Mifepristone inhibits GRbeta coupled prostate cancer cell proliferation. J Urol. 2012;188: 981-988.
47. Beck CA, Estes PA, Bona BJ, Muro-Cacho CA, Nordeen SK, Edwards DP. The steroid antagonist RU486 exerts different effects on the glucocorticoid and progesterone receptors. Endocrinology. 1993;133:728-740.
48. Morrissy S, Xu B, Aguilar D, Zhang J, Chen QM. Inhibition of apoptosis by progesterone in cardiomyocytes. Aging Cell. 2010;9:799-809.
49. Pecci A, Scholz A, Pelster D, Beato M. Progestins prevent apoptosis in a rat endometrial cell line and increase the ratio of bcl-XL to bcl-XS. J Biol Chem. 1997;272:11791-11798.
50. Doonan F, O'Driscoll C, Kenna P, Cotter TG. Enhancing survival of photoreceptor cells in vivo using the synthetic progestin Norgestrel. J Neurochem. 2011;118:915-927.
51. Cubilla MA, Bachor TP, Bermudez V, Marquioni MD, Suburo AM. Progesterone protects photoreceptors from light-induced damage. ARVO Meeting Abstracts. 2012;53:2565.
52. Frye CA, Llaneza DC. Corticosteroid and neurosteroid dysregulation in an animal model of autism, BTBR mice. Physiol Behav. 2010;100:264-267.
53. Issar M, Sahasranaman S, Buchwald P, Hochhaus G. Differences in the glucocorticoid to progesterone receptor selectivity of inhaled glucocorticoids. Eur Respir J. 2006;27:511-516.
54. Hill MN, McLaughlin RJ, Pan B, et al. Recruitment of prefrontal cortical endocannabinoid signaling by glucocorticoids contributes to termination of the stress response. J Neurosci. 2011;31:10506-10515.
55. Asagami T, Belanoff JK, Azuma J, Blasey CM, Clark RD, Tsao PS. Selective glucocorticoid receptor (GR-II) antagonist reduces body weight gain in mice. J Nutr Metab. 2011;2011:235389.
56. Pryce G, Giovannoni G, Baker D. Mifepristone or inhibition of 11beta-hydroxylase activity potentiates the sedating effects of the cannabinoid receptor-1 agonist Delta(9)-tetrahydrocannabinol in mice. Neurosci Lett. 2003;341:164-166.
57. Wulsin AC, Herman JP, Solomon MB. Mifepristone decreases depression-like behavior and modulates neuroendocrine and central hypothalamic-pituitary-adrenocortical axis responsiveness to stress. Psychoneuroendocrinology. 2010;35:1100-1112.
58. Zheng L, Anderson RE, Agbaga MP, Rucker EB III, Le YZ. Loss of BCL-XL in rod photoreceptors: increased susceptibility to bright light stress. Invest Ophthalmol Vis Sci. 2006;47:5583-5589.
59. Cringle SJ, Yu PK, Su EN, Yu DY. Oxygen distribution and consumption in the developing rat retina. Invest Ophthalmol Vis Sci. 2006;47:4072-4076.
60. Shuto M, Higuchi K, Sugiyama C, et al. Endogenous and exogenous glucocorticoids prevent trimethyltin from causing neuronal degeneration of the mouse brain in vivo: involvement of oxidative stress pathways. J Pharmacol Sci. 2009;110: 424-436.
61. Bouchard P, Chabbert-Buffet N, Fauser BC. Selective progesterone receptor modulators in reproductive medicine: pharmacology, clinical efficacy and safety. Fertil Steril. 2011;96: 1175-1189.
62. Schule C, Baghai TC, Eser D, Rupprecht R. Hypothalamicpituitary-adrenocortical system dysregulation and new treatment strategies in depression. Expert Rev Neurother. 2009;9: 1005-1019.
63. Nielsen JS, Jampol LM. Oral mifepristone for chronic central serous chorioretinopathy. Retina. 2011;31:1928-1936.